The document summarizes Indegene's omnichannel activation solution for life sciences companies. It notes that current go-to-market strategies are ineffective and costly due to HCPs receiving messages through fewer channels and changing preferences. Indegene offers a proprietary AI-driven solution using data on 1.8 million HCPs and their interactions to optimize omnichannel campaigns and augment field forces. Case studies show this approach increased revenue, lowered costs, and drove growth for mature drugs by reaching more HCPs.

1. The Indegene Difference
Omnichannel Activation
11 November 2022

2. HCPs are not receiving
messages when they
are receptive
HCPs are not receiving
information on the
channels they use most
Increased sales force
turnover
Face-to-face
interactions have
greatly diminished
HCP preferences are
evolving to prefer a
hybrid approach
Effectiveness of reps
and DTC has been
steadily decreasing
70%
of HCPs are not sure
pharma reps understand
their requirements
completely
Reps completely
understand my changing
needs and expectations
Reps understand my
changing needs and
expectations to some extent
Reps do not understand
my changing needs and
expectations
The current go-to-market strategy does not target HCPs effectively and results in
unnecessary costs, increasingly inefficient outcomes, and reduced ROI.
© 2022 Indegene. All rights reserved. 2

3. Indegene offers omnichannel activation
around the globe
22 Years
Of life sciences
expertise
4,500+
Passionate
employees
> 80
Markets served
globally
12
Therapeutic areas
> 100
Products launched
worldwide
1 million
Commercial and
medical assets created
Disruptive Go-To-Market Omnichannel
Activation Technology
Transform the
Status Quo
Turbocharge
Omnichannel
Strategies
Connect with
HCPs More
Effectively
Synergize Field Force with
Digital Engagement
Enable
Future-Ready Healthcare
The Indegene omnichannel
activation vision
© 2022 Indegene. All rights reserved. 3

4. © 2022 Indegene. All rights reserved. 4
The Indegene differentiated intelligent solution
An optimized hybrid go-to-market model that maximizes investment
Optimized Omnichannel Campaigns
Convert data into insight allowing for
highly effective segmentation
Create personalized content and deliver it
to the right person at the right time.
Proprietary AI-Driven IP
AI is leveraged by information on 1.8
million HCPs and over 300 million HCP
interactions across a full range of
therapeutic areas. Provide access to
proprietary HCP insights at the
individual level.
Augment Field Force Across the
Life Cycle
Omnichannel activation paired with
field force reduces cost and optimizes
results. Comparable impact as 800
reps with just 300 reps.
Omnichannel Indegene IP DRE Model

5. The Indegene proprietary IP + omnichannel activation
1.8 million HCP profiles provide
personalized detail at the NPI level.
Demographic
Information
Age, Gender, City, Zip
Specialty (Prim & Sec),
Practitioner type
Deep
Customer
Graphs
Technology engine to
dynamically choose the
high digital affinity doctors
Sequencing to
Rx (as proxy)
Indegene Digital decile
model will speed time to
conversion
Processed
through
Algorithm
Machine
Learning
and AI
Assess
Interaction
is Qualified
Model
Becomes
Smarter
HCP
Interaction &
Data Input
Built on AI that is continually
growing smarter and more
capable of effectively
segmenting HCPs
Indegene
Omnichannel Mix
EHR
Email
Social
Media
Virtual
Reps
Programmatic
Mobile
1.8 Million
HCPs
1.68 Million
HCPs
1.28 Million
HCPs
© 2022 Indegene. All rights reserved. 5

6. Digital Rep Equivalence
is already at work
© 2022 Indegene. All rights reserved. 6

7. © 2022 Indegene. All rights reserved. 7
$80 million
Revenue impact in
2.5 years
100%
Of the marketing team focus
on the primary indication
40%
Lower in Sales and
Marketing Cost
Indegene raises disease
awareness and targets
high potential HCPs to
drive revenue

8. Digital Rep Equivalence
drives growth for a
mature drug
© 2022 Indegene. All rights reserved. 8
30% á
Coverage
$100 million
Savings
10% á
Prescriptions in
whitespace

9. Thank you.